Multiple Myeloma (MM): Diagnosis, Treatment and Side Effect Management
Recorded on: November 20, 2024
Recorded on: November 20, 2024
Estimated Time to Complete: 1.75 hours
1.75 CE Credits/Contact hours for nurses and social workers available until: October 6, 2026
Format: Non-interactive recorded webinar
Target Audience
Oncology nurse practitioners, nurses, and social workers involved in the care of patients with multiple myeloma (MM).
Course content level for social workers: all levels
Description
This educational program provides a detailed overview of multiple myeloma (MM). Participants will acquire essential knowledge about the disease, including the pathophysiology, risk stratification, diagnostic criteria, and approved and emerging treatment options. The roles of the pharmacist, nurse, and social worker in caring for these patients and resources to support them will also be discussed. This program will provide participants with essential knowledge about MM to navigate their care and treatment effectively.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe an overview of multiple myeloma (MM)
- Identify tests used to diagnose disease and monitor treatment of MM
- Explain the overarching goals of treatment for MM
- Explain approved and emerging treatment options for MM, including stem cell transplantation, and the role of clinical trials
- Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for MM
- Describe the healthcare professional’s role in managing patients with MM
Faculty
Charise Gleason, MSN, NP-C, AOCNP
VP and Chief APP Officer
Emory Healthcare
NP Myeloma Program
Winship Cancer Institute of Emory University
Atlanta, GA
Sagar Lonial, MD
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA
Sara Scott, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute
Emory Healthcare
Atlanta, GA
Continuing Education Information
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.75 continuing education contact hours through the California Board of Registered Nursing.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.75 clinical continuing education credits.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.75 clinical CE contact hours for this activity.
Nurse Practitioner Continuing Education
This activity is approved for 1.75 contact hour(s) of continuing education (which includes 0.75 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 25037112. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.
If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@kimeglobal.com.
Providers
This activity is provided by The Leukemia & Lymphoma Society.
Supporters
There is no commercial support associated with this CE activity.
Participants gain access to the webinar via the participation button above.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.